DELEON TECHNOLOGIES, INC

Medtech

Low-cost disposable microfluidic chip for automated urinary biochemical analysis using capillary electrophoresis and laser-induced fluorescence detection

Grants
$305K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Enabling Daily Personalized Metabolomics with Low-Cost Capillary Electrophoresis$305,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
655REDUX HOLDINGS INC—$250K
656Iowa Adaptive Technologies, Inc.—$1.2M
657INFONDRIAN, LLC——
658DELEON TECHNOLOGIES, INC——
659NEW ENGLAND HEMOLYTICS, INC.——
660USHIFU LLC—$1.0M
661ASC Mercer Island LLC—$1.9M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.